# China NMPA Drug Inspection - Hainan Haishen Tongzhou Pharmaceutical Co., Ltd. - Clindamycin palmitate hydrochloride dry suspension

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hainan-haishen-tongzhou-pharmaceutical-co-ltd/9c0aa24a-cfc7-488b-bb87-3c990287dd8a/
Source feed: China

> China NMPA drug inspection for Hainan Haishen Tongzhou Pharmaceutical Co., Ltd. published September 03, 2018. Drug: Clindamycin palmitate hydrochloride dry suspension. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Jiangxi Province 2018 Drug Quality Bulletin
- Company Name: Hainan Haishen Tongzhou Pharmaceutical Co., Ltd.
- Publication Date: 2018-09-03
- Drug Name: Clindamycin palmitate hydrochloride dry suspension

Company: https://www.globalkeysolutions.net/companies/hainan-haishen-tongzhou-pharmaceutical-co-ltd/456f02c8-a85e-4574-afa5-1ef21fb4e035/